Protein palmitoylation and cancer

EMBO Rep. 2018 Oct;19(10):e46666. doi: 10.15252/embr.201846666. Epub 2018 Sep 19.

Abstract

Protein S-palmitoylation is a reversible post-translational modification that alters the localization, stability, and function of hundreds of proteins in the cell. S-palmitoylation is essential for the function of both oncogenes (e.g., NRAS and EGFR) and tumor suppressors (e.g., SCRIB, melanocortin 1 receptor). In mammalian cells, the thioesterification of palmitate to internal cysteine residues is catalyzed by 23 Asp-His-His-Cys (DHHC)-family palmitoyl S-acyltransferases while the removal of palmitate is catalyzed by serine hydrolases, including acyl-protein thioesterases (APTs). These enzymes modulate the function of important oncogenes and tumor suppressors and often display altered expression patterns in cancer. Targeting S-palmitoylation or the enzymes responsible for palmitoylation dynamics may therefore represent a candidate therapeutic strategy for certain cancers.

Keywords: S‐palmitoylation; lipid; lipidation; post‐translational modification; tumor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acyltransferases / genetics
  • Humans
  • Lipoylation / genetics*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Protein Processing, Post-Translational / genetics*
  • Proteolysis
  • Substrate Specificity

Substances

  • Neoplasm Proteins
  • Acyltransferases